SCHEMBL5951960

SCHEMBL5951960

CCC1Cc2c(cccc2-c2cccc3ccccc23)C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 3/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
HPGD P15428 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HTR1A P08908 2/20 0.43
BRD4 O60885 1/20 0.41
METAP1 P53582 3/20 0.39
CYP19A1 P11511 2/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SLC6A3 Q01959 1/20 0.37
ACHE P22303 3/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5952885 0.89 HTR7 (0.45) HTR7ALDH1A1MAPTHPGDMEN1
SCHEMBL5951597 0.85 MAPT (0.41) HTR7ALDH1A1MAPTHPGDMEN1
SCHEMBL3150632 0.80 ACHE (0.58) HTR7ALDH1A1MAPTHPGDMEN1
SCHEMBL1583277 0.80 METAP1 (0.42) HTR7HTR1AMETAP1CYP19A1ACHE
SCHEMBL5953322 0.80 HTR7 (0.43) HTR7ALDH1A1MAPTHPGDMEN1
SCHEMBL16775653 0.78 CYP19A1 (0.46) HTR7ALDH1A1MAPTHPGDMEN1
SCHEMBL5951742 0.77 HTR7 (0.43) HTR7ALDH1A1MAPTHPGDMEN1
SCHEMBL7627859 0.76 ACHE (0.62) METAP1CYP19A1ACHE
SCHEMBL16194381 0.76 CYP19A1 (0.46) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL9317264 0.75 METAP1 (0.46) HTR7HTR1AMETAP1CYP19A1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A HTR7 1861/4885ALDH1A1 317/4885MAPT 3693/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 HTR7 2049/4885ALDH1A1 198/4885MAPT 3748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.